首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Quinolone Resistance in Enterotoxigenic Escherichia coli Causing Diarrhea in Travelers to India in Comparison with Other Geographical Areas
【2h】

Note: Quinolone Resistance in Enterotoxigenic Escherichia coli Causing Diarrhea in Travelers to India in Comparison with Other Geographical Areas

机译:注意:与其他地理区域相比印度旅客产肠毒素的大肠杆菌中喹诺酮耐药性引起腹泻

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterotoxigenic Escherichia coli isolates were identified as a cause of traveler's diarrhea in 82 of 520 (16%) patients and tested for resistance to seven antimicrobial agents. Thirty patients (36%) needed antimicrobial therapy: 17 (56%) for persistence of symptoms and 13 (44%) for severity of symptoms. Ampicillin, tetracycline, and trimethoprim-sulfamethoxazole resistance was high. Chloramphenicol showed moderate activity, and amoxicillin plus clavulanic acid, nalidixic acid, and ciprofloxacin showed very good activity. Five nalidixic acid-resistant strains were isolated, four from patients visiting India.
机译:520例(16%)患者中有82例肠毒素原性大肠杆菌被认为是旅行者腹泻的原因,并测试了其对7种抗菌药物的耐药性。 30例患者(36%)需要抗微生物治疗:17例患者(56%)持续症状,13例患者(44%)症状严重。氨苄西林,四环素和甲氧苄啶-磺胺甲恶唑的耐药性较高。氯霉素显示中等活性,阿莫西林加克拉维酸,萘啶酸和环丙沙星显示非常好的活性。分离出五种耐萘啶酸的菌株,其中四种来自印度的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号